| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.6M | +26.0% |
| Cost of Revenue | $31.6M | -3.1% |
| R&D Expense | $17.3M | -48.7% |
| SG&A Expense | $44.5M | -32.8% |
| Operating Income | -$59.4M | +46.1% |
| Pre-tax Income | -$57.6M | +46.4% |
| Income Tax | $2K | -93.3% |
| Net Income | -$57.6M | +46.4% |
| EPS (Basic) | -$0.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.2M | -25.8% |
| Accounts Receivable | $9.9M | +64.4% |
| Inventory | $14.4M | -13.2% |
| Current Assets | $130.2M | -45.0% |
| Total Assets | $196.4M | -33.3% |
| Current Liabilities | $57.2M | -39.4% |
| Long-term Debt | $5.8M | -73.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.4M | -15.0% |
| Capital Expenditures | $766K | +134.3% |
| Investing Cash Flow | $72.9M | +44.4% |
| Financing Cash Flow | -$22.0M | — |
| Free Cash Flow | -$76.2M | -15.6% |
| +45.6% |
| EPS (Diluted) | -$0.37 | +45.6% |
| Total Liabilities |
| $85.2M |
| -32.0% |
| Stockholders' Equity | $111.2M | -34.3% |